Literature DB >> 18551269

[GreenLight laser vaporisation of the prostate for treatment of benign prostatic hyperplasia. Development and significance].

H-H Seifert1, T Hermanns, T Sulser.   

Abstract

GreenLight laser vaporisation has been successfully implemented in the treatment of benign prostatic hyperplasia in the last decade. Besides enhancement of the efficacy of the laser through increase of the power output to a maximum of 80 W and eventually 120 W, the encouraging clinical achievements resulted in a growing popularity of the laser system application. Swiss medical centres have been significantly involved in the evaluation of the clinical adoption of this surgical technique. Particularly the low peri- and post-operative morbidity as well as promising short- to medium-term functional results are noteworthy. In the present paper we present major results of the clinical evaluation of the technique. In addition to the important advantages of the technique, especially the virtually bloodless procedure, we also highlight the drawbacks and limitations of laser vaporisation, which possibly might entail adverse clinical effects. The future significance of this technique will thus have to be re-evaluated taking into account the yet unavailable long-term effects.

Entities:  

Mesh:

Year:  2008        PMID: 18551269     DOI: 10.1007/s00120-008-1776-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  14 in total

1.  Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation.

Authors:  Robin Ruszat; Stephen Wyler; Thomas Forster; Oliver Reich; Christian G Stief; Thomas C Gasser; Tullio Sulser; Alexander Bachmann
Journal:  Eur Urol       Date:  2006-08-18       Impact factor: 20.096

2.  The Next Generation in Laser Treatments and the Role of the GreenLight High-Performance System Laser.

Authors:  Alexis E Te
Journal:  Rev Urol       Date:  2006

Review 3.  Photoselective vaporization of the prostate (GreenLight PV): lessons learnt after 3500 procedures.

Authors:  F Gómez Sancha; A Bachmann; B B Choi; S Tabatabaei; G H Muir
Journal:  Prostate Cancer Prostatic Dis       Date:  2007-07-10       Impact factor: 5.554

4.  Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate.

Authors:  N J Barber; G Zhu; J F Donohue; P M Thompson; K Walsh; G H Muir
Journal:  Urology       Date:  2006-01       Impact factor: 2.649

5.  Photoselective vaporization of the prostate: the basel experience after 108 procedures.

Authors:  Alexander Bachmann; Robin Ruszat; Stephen Wyler; Oliver Reich; Helge H Seifert; Alexander Müller; Tullio Sulser
Journal:  Eur Urol       Date:  2005-03-02       Impact factor: 20.096

6.  High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later.

Authors:  R S Malek; D M Barrett; R S Kuntzman
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

7.  KTP laser versus transurethral resection: early results of a randomized trial.

Authors:  David M Bouchier-Hayes; Paul Anderson; Scott Van Appledorn; Pat Bugeja; Anthony J Costello
Journal:  J Endourol       Date:  2006-08       Impact factor: 2.942

8.  Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.

Authors:  Alexander Bachmann; Leander Schürch; Robin Ruszat; Stephen F Wyler; Hans-Helge Seifert; Alexander Müller; Kurt Lehmann; Tullio Sulser
Journal:  Eur Urol       Date:  2005-07-18       Impact factor: 20.096

9.  Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate.

Authors:  Thomas Hermanns; Tullio Sulser; Markus Fatzer; Martin K Baumgartner; Julien M Rey; Markus W Sigrist; Hans-Helge Seifert
Journal:  Eur Urol       Date:  2008-03-27       Impact factor: 20.096

10.  Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective study.

Authors:  Gerasimos Alivizatos; Andreas Skolarikos; Dimitrios Chalikopoulos; Christos Papachristou; Odysseas Sopilidis; Athanasios Dellis; Ioannis Kastriotis; Charalambos Deliveliotis
Journal:  Eur Urol       Date:  2007-11-29       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.